Investment Rating - The report maintains a "Positive" investment rating for the chemical industry [8] Core Insights - The light initiator industry is experiencing frequent supply disruptions, with significant events such as a fire at Jiangxi Yangfan's subsidiary leading to production halts, and Ningxia Wokailong facing operational difficulties. Despite these challenges, the industry's high concentration and growing demand suggest a potential recovery in market conditions, making it a point of interest for investment opportunities [2][7] Summary by Sections Industry Overview - The light initiator industry is crucial for light-curing materials, which include UV coatings, inks, adhesives, and composites. The market has seen stable growth, with the output value increasing from 3.11 billion in 2018 to 4.59 billion in 2023, reflecting a CAGR of 8.1% [10] Supply Disruptions - Recent supply disruptions include a fire incident at Jiangxi Yangfan and operational challenges faced by Ningxia Wokailong, which has been listed as a dishonest executor due to unfulfilled obligations. These events are expected to improve the supply-demand balance in the industry [7][10] Market Dynamics - Historical price elasticity in the light initiator market indicates significant upward potential, especially as the current market conditions are at a low point. The report notes that in 2017, prices surged due to high demand and limited supply, with notable increases in various product prices [10] Investment Opportunities - The report suggests focusing on key players like Jiu Ri New Materials, which holds a leading position in the market with a projected production of 19,851 tons in 2024, capturing approximately 34% of the domestic market share. The company is expected to increase its sales by 20.2% year-on-year, indicating a strong competitive advantage [10]

Group 1 - The A-share photoresist concept has experienced significant upward movement, with Xingye Co., Ltd. hitting the daily limit [1] - Other companies such as Aisikai, Jiuri New Materials, Ruilian New Materials, Baotong Technology, Huamao Technology, and Guolin Technology also saw increases in their stock prices [1]

Core Viewpoint - The fire incident at Jiangxi Yangfan's workshop may impact the supply of light curing agent intermediates, particularly affecting the production of light curing agent 907, which is crucial for various applications including PCB inks and fine chemicals [3][4]. Group 1: Incident Overview - On June 9, 2025, a fire occurred at Jiangxi Yangfan, a wholly-owned subsidiary of Yangfan New Materials, resulting in one employee sustaining minor burns [3]. - The local emergency management bureau has mandated Jiangxi Yangfan to halt production and operations for rectification [3]. Group 2: Production Capacity and Revenue Impact - Jiangxi Yangfan has an intermediate production capacity of 3,170 tons, contributing approximately 47.3% of Yangfan New Materials' total revenue of 346 million yuan in 2024 [3]. - The company also has additional production capacities in Inner Mongolia (15,275 tons) and a new facility in Zhejiang (2,200 tons) [3]. Group 3: Market Demand and Supply Dynamics - The demand for light curing agent 907 is driven by the PCB industry, which is experiencing growth due to the recovery in electronic consumer products and the rising computational needs of emerging industries like AI [4]. - Major suppliers of light curing agent 907 in China include Jiurich New Materials and Yangfan New Materials, with the latter relying on intermediates like mercaptan compounds for production [4]. Group 4: Price Trends and Market Outlook - The market for light curing agents has seen continuous growth in production and sales, although prices have fluctuated significantly due to regulatory policies and external factors [5]. - Following a period of price decline from 2020 to 2023, the prices of light curing agents are expected to stabilize and potentially recover as unfavorable factors dissipate, benefiting leading companies in the industry [5].

Core Viewpoint - Jiu Ri New Materials (688199.SH) reported a revenue of 1.488 billion yuan for 2024, marking a year-on-year increase of 20.52%, while the net profit attributable to shareholders was a loss of 53.76 million yuan, an improvement from the previous year's loss of 96.14 million yuan [1][2] Financial Performance Summary - **Revenue**: The company achieved an operating revenue of 1.488 billion yuan in 2024, up 20.52% from 1.234 billion yuan in 2023 [1][2] - **Net Profit**: The net profit attributable to shareholders was -53.76 million yuan, compared to -96.14 million yuan in the previous year, indicating a reduction in losses [1][2] - **Net Profit Excluding Non-Recurring Items**: The net profit excluding non-recurring items was -62.78 million yuan, an improvement from -113.03 million yuan year-on-year [1][2] - **Cash Flow**: The net cash flow from operating activities was 74.14 million yuan, reflecting a year-on-year increase of 3.84% [1][2] 2025 Q1 Performance Summary - **Revenue**: In the first quarter of 2025, the company reported an operating revenue of 356.04 million yuan, a slight decrease of 0.15% compared to 356.58 million yuan in the same period last year [3][4] - **Net Profit**: The net profit attributable to shareholders was -10.52 million yuan, worsening from -4.39 million yuan in the previous year [3][4] - **Net Profit Excluding Non-Recurring Items**: The net profit excluding non-recurring items was -11.00 million yuan, compared to -8.93 million yuan year-on-year [3][4] - **Cash Flow**: The net cash flow from operating activities was -48.20 million yuan, compared to -38.89 million yuan in the same period last year [3][4] Company Background - Jiu Ri New Materials was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 5, 2019, with an issuance of 27.81 million shares at a price of 66.68 yuan per share [4] - The total amount raised from the issuance was 1.854 billion yuan, with a net amount of 1.709 billion yuan, exceeding the original plan by 113.87 million yuan [5] - The company plans to use the raised funds for the construction of a production project for 87,000 tons of light-curing materials and for working capital [5]

证券代码：688199 证券简称：久日新材 公告编号：2025-032 天津久日新材料股份有限公司 关于签署募集资金三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意天津久日新材料股份有限公司首次公 开发行股票注册的批复》（证监许可[2019]1887 号），同意公司首次公开发行 股票的注册申请，公司向社会公开发行人民币普通股 2,780.68 万股，每股面值 人民币 1.00 元，每股发行价为人民币 66.68 元，共募集资金人民币 185,415.74 万元，扣除发行费用 14,486.45 万元（不含税），实际募集资金净额为人民币 170,929.30 万元。前述募集资金到位情况经大华会计师事务所（特殊普通合伙） 验证，并出具了《天津久日新材料股份有限公司发行人民币普通股（A 股） 2,780.68 万股后实收股本的验资报告》（大华验字[2019]000423 号）。公司已 对募集资金进行了专户存储，并与保荐机构、存放募集资金的商业银行签署了募 ...

Investment Rating - The report provides a standard investment rating for the basic chemical industry, indicating a cautious outlook due to recent market fluctuations and supply chain disruptions [1]. Core Insights - Japan's Mitsui Chemicals is exiting the NF3 business, which may enhance China's competitiveness in electronic specialty gases, with potential market share expansion [4][10]. - The chlorantraniliprole incident has caused supply disruptions, potentially boosting the market for pesticides and intermediates, with a shift towards high-efficiency, low-toxicity products [4][12]. - The report suggests focusing on key sub-sectors such as integrated refining and petrochemical chains, refrigerant industry leaders, and domestic alternative materials [4][14]. Summary by Sections 1. Industry News and Event Commentary - Mitsui Chemicals' exit from the NF3 business is attributed to rising competition and costs, indicating that Chinese manufacturers may fill the gap and increase exports [10][11]. - The chlorantraniliprole incident is expected to accelerate market consolidation, benefiting companies with technological advantages and regulatory compliance [12][13]. 2. Chemical Sector Weekly Performance - For the week of May 26 to May 30, the Shanghai Composite Index fell by 1.08%, while the Shenwan Petroleum and Petrochemical Index rose by 0.40%, outperforming the market by 1.48 percentage points [15][18]. - The basic chemical index decreased by 0.66%, ranking 23rd among all Shenwan primary industries [15][18]. 3. Key Product Price and Spread Performance - Notable price increases included potassium chloride (up 5.66%) and paraxylene (up 4.94%), while hydrochloric acid saw a significant drop of 28.00% [27][28]. - The price spread for carbon black increased by 31.13%, indicating a tightening supply situation [29][30].

Investment Rating - The report provides a standard investment rating for the basic chemical industry, indicating a cautious outlook due to recent market fluctuations and supply chain disruptions [4]. Core Insights - The exit of Japan's Mitsui Chemicals from the nitrogen trifluoride (NF3) business is expected to enhance China's competitiveness in electronic specialty gases, with potential for increased market share [10][11]. - Supply disruptions from incidents like the chlorantraniliprole event are likely to boost the market outlook for pesticides and intermediates, leading to a potential price recovery in the short term [12][13]. - The report emphasizes the importance of monitoring key sub-sectors and suggests investment opportunities in integrated supply chains and leading companies within the chemical industry [14]. Summary by Sections 1. Industry News and Event Commentary - Mitsui Chemicals announced its exit from the NF3 business, with production ceasing by March 2026, indicating a shift in market dynamics favoring Chinese producers [10]. - A chemical company experienced an explosion, impacting the chlorantraniliprole supply chain, which may lead to a consolidation of market players and a potential price increase for certain pesticide products [12][13]. 2. Chemical Sector Weekly Performance - For the week of May 26 to May 30, the Shanghai Composite Index fell by 1.08%, while the Shenwan Petroleum and Petrochemical Index rose by 0.40%, outperforming the market [15]. - The basic chemical index decreased by 0.66%, ranking 23rd among all Shenwan primary industries [15]. 3. Key Product Price Movements - Notable price increases included potassium chloride (up 5.66%) and paraxylene (up 4.94%), while hydrochloric acid saw a significant drop of 28.00% [27][28]. - The report highlights the price fluctuations of key products, indicating a volatile market environment that could present both risks and opportunities for investors [27][28]. 4. Investment Recommendations - The report suggests focusing on integrated players in the refining-PX-PTA chain, leading fluorochemical companies, and firms in the domestic substitution of new materials [14]. - Specific companies highlighted for potential investment include Hengli Petrochemical, Rongsheng Petrochemical, and various leaders in the semiconductor materials sector [14].

天津久日新材料股份有限公司 第五届监事会第二十三次会议决议公告 证券代码：688199 证券简称：久日新材 公告编号：2025-028 表决结果：同意 3 票；反对 0 票；弃权 0 票 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 天津久日新材料股份有限公司（以下简称公司）第五届监事会第二十三次会 议（以下简称本次会议）于 2025 年 5 月 27 日在公司会议室以现场和通讯相结合 的方式召开，本次会议通知已于 2025 年 5 月 21 日以专人送出等方式送达全体监 事。本次会议应出席监事 3 人，实际出席监事 3 人，由监事会主席罗想先生召集 并主持。本次会议的召开符合《中华人民共和国公司法》及《天津久日新材料股 份有限公司章程》（以下简称《公司章程》）等有关法律、法规、规范性文件的 规定，程序合法。 二、监事会会议审议情况 经与会监事认真讨论，审议并通过如下事项： （一）审议通过《关于使用部分募集资金向控股孙公司提供借款以实施募 投项目的议案》 经与会监事审议，公司监事会认为：公司本次使 ...

天津久日新材料股份有限公司（以下简称公司）于 2025 年 5 月 27 日召开第 五届董事会第二十四次会议、第五届监事会第二十三次会议，审议通过《关于使 用部分募集资金向控股孙公司提供借款以实施募投项目的议案》，同意公司使用 募集资金 5,000.00 万元向控股孙公司湖南弘润化工科技有限公司（以下简称弘 润化工）提供借款，用于实施湖南弘润化工科技有限公司 8,000 吨/年光引发剂 H4 酮项目（以下简称弘润化工项目）。该事项在公司董事会审议权限范围内， 无需提交股东大会审议。公司监事会、保荐机构对该事项发表了同意的意见。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意天津久日新材料股份有限公司首次公 开发行股票注册的批复》（证监许可20191887 号），同意公司首次公开发行 股票的注册申请，公司向社会公开发行人民币普通股 2,780.68 万股，每股面值 人民币 1.00 元，每股发行价为人民币 66.68 元，共募集资金人民币 185,415.74 万元，扣除发行费用 14,486.45 万元（不含税），实际募集资金净额为人民币 验证，并出具了《天津久日新材料股份有限公司发行人民币普通股（ ...

Core Viewpoint - The company announces a reduction in its capital contribution to the Tianjin Haihe Bohong New Materials Equity Investment Fund, which constitutes a related party transaction, following the fund's exit from certain investments and the need for capital adjustment [1][2][4]. Summary by Sections Transaction Overview - The Tianjin Haihe Bohong Fund reduced its capital contribution from CNY 150 million to CNY 134.78 million after exiting investments in Shandong Kaisheng New Materials Co., Ltd. and Tianjin Jiurui Biotechnology Co., Ltd., receiving a total of CNY 15.218 million [1][4][8]. - The company holds a 19.80% stake in the Haihe Bohong Fund, which is managed by Tianjin Ruixing Investment Management Co., Ltd., a related party in which the company owns 40% [1][5]. Related Party Transaction - The reduction in capital does not constitute a major asset restructuring and is within the board's approval authority, thus not requiring a shareholder meeting [2][3]. - The company has previously approved a reduction in its capital contribution to the fund from CNY 99 million to CNY 29.7 million due to changes in the fund's circumstances [3][4]. Financial Data - The Haihe Bohong Fund's total assets were reported at CNY 301.58 million, with net assets of CNY 301.54 million, and a net profit of CNY 5.44 million for the last audited year [6][7]. - The fund's financial performance showed a significant loss in the previous year, indicating a need for capital restructuring [7]. Approval Process - The board of directors and the supervisory board unanimously approved the capital reduction and related party transaction, confirming compliance with legal and regulatory requirements [12][13]. - Independent directors also supported the transaction, stating it aligns with the fund's operational needs and does not harm shareholder interests [12][13].